MEGAN DIETRICH: Open Payments
NPI 1922714674 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$930 in 48 payments from 25 companies in 2025. Trend: 2023 $111 · 2024 $1,098 · 2025 $930
Food & beverage: $930
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $213 |
| Incyte Corporation | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
| Merck Sharp & Dohme LLC | 2 | $53 |
| BeOne Medicines USA, Inc. | 2 | $52 |
| Genentech USA, Inc. | 2 | $45 |
| ABBVIE INC. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Eisai Inc. | 1 | $35 |
| Janssen Biotech, Inc. | 2 | $35 |
Products named: KISQALI, JAKAFI, BRUKINSA, JEMPERLI, SCEMBLIX, EPKINLY, Lenvima, SIR-Spheres Microspheres.
Industry payments across MI — which companies pay providers there.
